Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM ; volume:16 ; number:1 ; day:31 ; month:1 ; year:2015 ; pages:1-9 ; date:12.2015
BMC immunology ; 16, Heft 1 (31.1.2015), 1-9, 12.2015
- Creator
-
Deng, Zhenling
Wu, Yanhong
Ma, Wenbo
Zhang, Shuren
Zhang, Yu-Qian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12865-014-0064-x
- URN
-
urn:nbn:de:101:1-2021082120000230648495
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Deng, Zhenling
- Wu, Yanhong
- Ma, Wenbo
- Zhang, Shuren
- Zhang, Yu-Qian
- SpringerLink (Online service)
Other Objects (12)
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell therapy for Leukemia
T-cell clonotypes in cancer
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Effects of EpCAM overexpression on human breast cancer cell lines
Ligand-based adoptive T cell targeting CA125 in ovarian cancer
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell therapy for Leukemia
T-cell clonotypes in cancer
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Effects of EpCAM overexpression on human breast cancer cell lines
Ligand-based adoptive T cell targeting CA125 in ovarian cancer
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell therapy for Leukemia
T-cell clonotypes in cancer
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Effects of EpCAM overexpression on human breast cancer cell lines
Ligand-based adoptive T cell targeting CA125 in ovarian cancer
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy